AXGN
AxoGen, Inc.$41.71+2.32 (+5.89%)Prev Close$39.39·MCap$1.86B·P/E—·Vol2.20M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
25
$14.17M
◆
Net Activity
Net Seller
$14.17M
●
Active Insiders
11
last 12 mo
Over the past 12 months, insider activity at AxoGen, Inc. (AXGN) has been exclusively selling, with 0 insider purchases totaling $0.00 and 25 insider sales totaling $14.17M. The most recent insider transaction was by DeVinney Erick Wayne (officer: Chief Innovation Officer), who sold $171.5K worth of shares on Mar 18, 2026. AxoGen, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $1.86B.
AXGN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | DeVinney Erick Wayne | officer: Chief Innovation Officer | Sell | 5,221 | $32.84 | $171.5K | 262,781 |
| Dec 16, 2025 | Weiler Kathy Johnson | Director | Sell | 46,653 | $29.55 | $1.38M | 0 |
| Dec 16, 2025 | Wendell Amy McBride | Director | Sell | 43,684 | $29.31 | $1.28M | 0 |
| Dec 15, 2025 | Hartley Lindsey Marie | CFO | Sell | 14,812 | $29.86 | $442.3K | 0 |
| Dec 11, 2025 | Began Marc A | EVP & General Counsel | Sell | 13,222 | $30.00 | $396.7K | 0 |
| Dec 10, 2025 | DALE MICHAEL D | Chief Executive Officer | Sell | 25,000 | $30.00 | $750.0K | 0 |
| Dec 9, 2025 | Began Marc A | EVP & General Counsel | Sell | 9,278 | $31.21 | $289.5K | 0 |
| Dec 9, 2025 | DALE MICHAEL D | Chief Executive Officer | Sell | 61,463 | $31.21 | $1.92M | 0 |
| Dec 9, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 19,517 | $31.21 | $609.1K | 0 |
| Dec 9, 2025 | Kemp Jens | Chief Marketing Officer | Sell | 8,156 | $31.21 | $254.5K | 0 |
| Dec 9, 2025 | THOMAS PAUL | Director | Sell | 21,399 | $29.61 | $633.7K | 0 |
| Dec 9, 2025 | TYNDALL JOSEPH A. | Director | Sell | 25,108 | $30.98 | $777.8K | 0 |
| Dec 8, 2025 | Hartley Lindsey Marie | CFO | Sell | 14,387 | $31.56 | $454.0K | 0 |
| Dec 8, 2025 | JOHNSON JOHN | Director | Sell | 45,379 | $30.64 | $1.39M | 0 |
| Nov 10, 2025 | Burke William P. Mr. | Director | Sell | 22,818 | $24.01 | $547.9K | 0 |
| Nov 5, 2025 | Burke William P. Mr. | Director | Sell | 16,778 | $24.04 | $403.3K | 0 |
| Oct 29, 2025 | Burke William P. Mr. | Director | Sell | 58,483 | $21.32 | $1.25M | 0 |
| Oct 22, 2025 | Burke William P. Mr. | Director | Sell | 1,457 | $18.02 | $26.3K | 0 |
| Oct 6, 2025 | Burke William P. Mr. | Director | Sell | 736 | $18.00 | $13.2K | 0 |
| Oct 2, 2025 | Burke William P. Mr. | Director | Sell | 32,191 | $18.14 | $584.1K | 0 |
| Sep 13, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 1,137 | $16.29 | $18.5K | 0 |
| Jun 10, 2025 | TYNDALL JOSEPH A. | Director | Sell | 26,931 | $10.72 | $288.7K | 0 |
| Jun 9, 2025 | Weiler Kathy Johnson | Director | Sell | 4,073 | $10.61 | $43.2K | 0 |
| May 22, 2025 | TYNDALL JOSEPH A. | Director | Sell | 20,062 | $11.20 | $224.7K | 0 |
| May 19, 2025 | TYNDALL JOSEPH A. | Director | Sell | 2,525 | $11.63 | $29.4K | 0 |
| Mar 16, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 15,111 | $17.50 | $264.4K | 0 |
| Mar 4, 2025 | Kemp Jens | Chief Marketing Officer | Sell | 4,003 | $18.36 | $73.5K | 0 |
| Mar 3, 2025 | Wendell Amy McBride | Director | Sell | 5,000 | $20.02 | $100.1K | 0 |
| Mar 1, 2025 | Began Marc A | EVP & General Counsel | Sell | 5,901 | $18.36 | $108.3K | 0 |
| Feb 28, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 8,296 | $18.35 | $152.2K | 0 |
| Feb 22, 2025 | Began Marc A | EVP & General Counsel | Sell | 814 | $16.50 | $13.4K | 0 |
| Feb 22, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 972 | $16.50 | $16.0K | 0 |
| Feb 22, 2025 | Kemp Jens | Chief Marketing Officer | Sell | 814 | $16.49 | $13.4K | 0 |
| Jan 6, 2025 | Naor Nir | CFO | Sell | 39,132 | $15.22 | $595.6K | 0 |
| Mar 16, 2024 | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 4,578 | $7.68 | $35.2K | 0 |
| Mar 16, 2024 | Donovan Michael Patrick | VP Operations | Sell | 4,596 | $7.68 | $35.3K | 0 |
| Mar 16, 2024 | Scopelianos Angelo | Chief R&D Officer | Sell | 6,881 | $7.68 | $52.8K | 0 |
| Mar 16, 2024 | Zaderej Karen L. | CEO | Sell | 39,280 | $7.68 | $301.7K | 0 |
| Mar 7, 2024 | Donovan Michael Patrick | VP Operations | Sell | 36,310 | $8.81 | $319.9K | 0 |
| Mar 7, 2024 | Freitag Gregory Gene | Director | Sell | 25,000 | $9.00 | $225.0K | 0 |
| Dec 11, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 12,500 | $7.50 | $93.8K | 0 |
| Sep 6, 2023 | Wendell Amy McBride | Director | Buy | 10,000 | $6.22 | $62.2K | 0 |
| Aug 23, 2023 | Burke William P. Mr. | Director | Buy | 10,000 | $6.56 | $65.6K | 0 |
| Aug 16, 2023 | NEELS GUIDO J | Director | Buy | 10,000 | $6.11 | $61.1K | 0 |
| Jul 18, 2023 | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 864 | $4.04 | $3.5K | 0 |
| Jul 18, 2023 | Donovan Michael Patrick | VP Operations | Sell | 1,403 | $4.04 | $5.7K | 0 |
| Jul 18, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 3,263 | $4.04 | $13.2K | 0 |
| Jun 1, 2023 | Freitag Gregory Gene | Director | Sell | 41,980 | $8.71 | $365.8K | 0 |
| May 23, 2023 | Freitag Gregory Gene | Director | Sell | 7,468 | $9.23 | $68.9K | 0 |
| Mar 16, 2023 | Donovan Michael Patrick | VP Operations | Sell | 2,769 | $8.27 | $22.9K | 0 |
Showing 1–50 of 108
1 / 3
AXGN Insider Buying Activity
The following table shows recent insider purchases of AxoGen, Inc. (AXGN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 6, 2023 | Wendell Amy McBride | Director | Buy | 10,000 | $6.22 | $62.2K | 0 |
| Aug 23, 2023 | Burke William P. Mr. | Director | Buy | 10,000 | $6.56 | $65.6K | 0 |
| Aug 16, 2023 | NEELS GUIDO J | Director | Buy | 10,000 | $6.11 | $61.1K | 0 |
AXGN Insider Selling Activity
The following table shows recent insider sales of AxoGen, Inc. (AXGN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | DeVinney Erick Wayne | officer: Chief Innovation Officer | Sell | 5,221 | $32.84 | $171.5K | 262,781 |
| Dec 16, 2025 | Weiler Kathy Johnson | Director | Sell | 46,653 | $29.55 | $1.38M | 0 |
| Dec 16, 2025 | Wendell Amy McBride | Director | Sell | 43,684 | $29.31 | $1.28M | 0 |
| Dec 15, 2025 | Hartley Lindsey Marie | CFO | Sell | 14,812 | $29.86 | $442.3K | 0 |
| Dec 11, 2025 | Began Marc A | EVP & General Counsel | Sell | 13,222 | $30.00 | $396.7K | 0 |
| Dec 10, 2025 | DALE MICHAEL D | Chief Executive Officer | Sell | 25,000 | $30.00 | $750.0K | 0 |
| Dec 9, 2025 | Began Marc A | EVP & General Counsel | Sell | 9,278 | $31.21 | $289.5K | 0 |
| Dec 9, 2025 | DALE MICHAEL D | Chief Executive Officer | Sell | 61,463 | $31.21 | $1.92M | 0 |
| Dec 9, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 19,517 | $31.21 | $609.1K | 0 |
| Dec 9, 2025 | Kemp Jens | Chief Marketing Officer | Sell | 8,156 | $31.21 | $254.5K | 0 |
| Dec 9, 2025 | THOMAS PAUL | Director | Sell | 21,399 | $29.61 | $633.7K | 0 |
| Dec 9, 2025 | TYNDALL JOSEPH A. | Director | Sell | 25,108 | $30.98 | $777.8K | 0 |
| Dec 8, 2025 | Hartley Lindsey Marie | CFO | Sell | 14,387 | $31.56 | $454.0K | 0 |
| Dec 8, 2025 | JOHNSON JOHN | Director | Sell | 45,379 | $30.64 | $1.39M | 0 |
| Nov 10, 2025 | Burke William P. Mr. | Director | Sell | 22,818 | $24.01 | $547.9K | 0 |
| Nov 5, 2025 | Burke William P. Mr. | Director | Sell | 16,778 | $24.04 | $403.3K | 0 |
| Oct 29, 2025 | Burke William P. Mr. | Director | Sell | 58,483 | $21.32 | $1.25M | 0 |
| Oct 22, 2025 | Burke William P. Mr. | Director | Sell | 1,457 | $18.02 | $26.3K | 0 |
| Oct 6, 2025 | Burke William P. Mr. | Director | Sell | 736 | $18.00 | $13.2K | 0 |
| Oct 2, 2025 | Burke William P. Mr. | Director | Sell | 32,191 | $18.14 | $584.1K | 0 |
| Sep 13, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 1,137 | $16.29 | $18.5K | 0 |
| Jun 10, 2025 | TYNDALL JOSEPH A. | Director | Sell | 26,931 | $10.72 | $288.7K | 0 |
| Jun 9, 2025 | Weiler Kathy Johnson | Director | Sell | 4,073 | $10.61 | $43.2K | 0 |
| May 22, 2025 | TYNDALL JOSEPH A. | Director | Sell | 20,062 | $11.20 | $224.7K | 0 |
| May 19, 2025 | TYNDALL JOSEPH A. | Director | Sell | 2,525 | $11.63 | $29.4K | 0 |
| Mar 16, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 15,111 | $17.50 | $264.4K | 0 |
| Mar 4, 2025 | Kemp Jens | Chief Marketing Officer | Sell | 4,003 | $18.36 | $73.5K | 0 |
| Mar 3, 2025 | Wendell Amy McBride | Director | Sell | 5,000 | $20.02 | $100.1K | 0 |
| Mar 1, 2025 | Began Marc A | EVP & General Counsel | Sell | 5,901 | $18.36 | $108.3K | 0 |
| Feb 28, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 8,296 | $18.35 | $152.2K | 0 |
| Feb 22, 2025 | Began Marc A | EVP & General Counsel | Sell | 814 | $16.50 | $13.4K | 0 |
| Feb 22, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 972 | $16.50 | $16.0K | 0 |
| Feb 22, 2025 | Kemp Jens | Chief Marketing Officer | Sell | 814 | $16.49 | $13.4K | 0 |
| Jan 6, 2025 | Naor Nir | CFO | Sell | 39,132 | $15.22 | $595.6K | 0 |
| Mar 16, 2024 | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 4,578 | $7.68 | $35.2K | 0 |
| Mar 16, 2024 | Donovan Michael Patrick | VP Operations | Sell | 4,596 | $7.68 | $35.3K | 0 |
| Mar 16, 2024 | Scopelianos Angelo | Chief R&D Officer | Sell | 6,881 | $7.68 | $52.8K | 0 |
| Mar 16, 2024 | Zaderej Karen L. | CEO | Sell | 39,280 | $7.68 | $301.7K | 0 |
| Mar 7, 2024 | Donovan Michael Patrick | VP Operations | Sell | 36,310 | $8.81 | $319.9K | 0 |
| Mar 7, 2024 | Freitag Gregory Gene | Director | Sell | 25,000 | $9.00 | $225.0K | 0 |
| Dec 11, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 12,500 | $7.50 | $93.8K | 0 |
| Jul 18, 2023 | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 864 | $4.04 | $3.5K | 0 |
| Jul 18, 2023 | Donovan Michael Patrick | VP Operations | Sell | 1,403 | $4.04 | $5.7K | 0 |
| Jul 18, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 3,263 | $4.04 | $13.2K | 0 |
| Jun 1, 2023 | Freitag Gregory Gene | Director | Sell | 41,980 | $8.71 | $365.8K | 0 |
| May 23, 2023 | Freitag Gregory Gene | Director | Sell | 7,468 | $9.23 | $68.9K | 0 |
| Mar 16, 2023 | Donovan Michael Patrick | VP Operations | Sell | 2,769 | $8.27 | $22.9K | 0 |
AXGN Insiders
Similar Stocks to AXGN
ABT
Abbott Laboratories
$93.53+0.80%
$166.85B
SYK
Stryker Corporation
$321.11-2.38%
$129.58B
BSX
Boston Scientific Corporation
$58.34-2.68%
$90.64B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$287.57+0.00%
$47.35B
EW
Edwards Lifesciences Corporation
$81.85-1.93%
$47.30B
DXCM
DexCom, Inc.
$59.34-3.35%
$24.16B
ZBH
Zimmer Biomet Holdings, Inc.
$82.88-10.49%
$18.14B
ALGN
Align Technology, Inc.
$176.49-4.45%
$13.98B